Article information
Full text is only aviable in PDF
Bibliografía
[1.]
Statement of the American Thoracic Society and European Respiratory Society.
Skeletal muscle dysfunction in chronic obstructive pulmonary disease.
Am J Respir Crti Care Med, 159 (1999), pp. 51-540
[2.]
K.J. Killian, P. Le Blanc, D.H. Martin, E. Summers, N.L. Jones, E.J.M. Campbell.
Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with airflow limitation.
Am Rev Respir Dis, 146 (1992), pp. 935-940
[3.]
A.L. Hamilton, K.J. Killian, E. Summers, N.L. Jones.
Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders.
Am J Respir Crit Care Med, 152 (1995), pp. 2021-2031
[4.]
P. Jakobsson, L. Jorfeldt, J. Henriksson.
Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 151 (1995), pp. 374-377
[5.]
J.F. Payen, B. Wuyam, P. Levy, H. Reutemaner, P. Stieglitz, B. Poramelle, et al.
Muscular metabolism during oxygen supplementation in patients with chronic hypoxemia.
Am Rev Respir Dis, 147 (1993), pp. 592-598
[6.]
M. Decramer, R. Gosselink, T. Troosters, M. Verschueren, G. Evers.
Muscle weakness is related to utilization of health care resources in COPD patients.
Eur Respir J, 10 (1997), pp. 417-423
[7.]
J.P. Knochel.
Neuromuscular manifestations of electrolyte disorders.
Am J Med, 72 (1982), pp. 521-535
[8.]
J. Fisher, N. Magid, C. Kallman, M. Fanucchi, L. Klein, D. McCarthy, et al.
Respiratory illness and hypophosphatemia.
Chest, 83 (1983), pp. 504-508
[9.]
E. Fiaccadori, E. Coffrini, N. Ronda, A. Vezzani, G. Cacciani, C. Fracchia, et al.
Hypophosphatemia in course of chronic obstructive pulmonary disease.
Chest, 97 (1990), pp. 857-868
[10.]
M.G. Betro, R.W. Pain.
Hypophosphatemia and hyperphosphatemia in a hospital population.
Br Med J, 1 (1972), pp. 273-276
[11.]
M. Lotz, R. Nay, F.C. Bartter.
Osteomalacia and debility resulting from phosphorus depletion.
Trans Assoc Am Physicians, 77 (1964), pp. 281
[12.]
M. Aubier, D. Murciano, Y. Lecocguic, N. Viires, Y. Jacquens, P. Squara, et al.
Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure.
N Engl J Med, 313 (1985), pp. 420-424
[13.]
S.R. Rannels, D.E. Rannels, A.E. Pegg, L.S. Jefferson.
Glucocorticoid effects on peptide-chain initiation in skeletal muscle and heart.
Am J Physiol, 235 (1978), pp. E134-E139
[14.]
M. Decramer, V. De Bock, R. Dom.
Functional and histologic pattern of steroid-induced myopathy in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 153 (1996), pp. 1956-1964
[15.]
F.K. Lieu, S.K. Powers, R.A. Herb, D. Criswell, D. Martin, C.H. Wood, et al.
Exercise and glucocorticoid-induced diaphragmatic myopathy.
J Appl Physiol, 75 (1993), pp. 763-771
[16.]
M. Decramer, L.M. Lacquet, R. Fagard, P.H. Rogiers.
Corticosteroids contribute to musckle weakness in chronic airflow obstruction.
Am J Respir Crit Care Med, 150 (1994), pp. 11-16
[17.]
P.N.R. Dekhuijzen, G. Gayan-ramirez, V. De Bock, R. Dom, M. Decramer.
Triamcinolone and prednisolone affect contractile properties and histopatology of rat diaphragm differently.
J Clin Invest, 92 (1993), pp. 1534-1542
[18.]
R.H.H. VanBalkom, H.F.M. Van der Heijden, H.T.B. Van Moerkerk, J.H. Veerkamp, J.A.M. Fransen, L.A. Ginsel, et al.
Effects of different treatment regimens of methylprednisolone on rat diaphragm contractility, immunohistochemistry and biochemistry.
Eur Respir J, 9 (1996), pp. 1217-1223
[19.]
J.D. MacDougall, G.C.B. Elder, D.G. Sale, J.R. Moroz, J.R. Sutton.
Effects of strength training and immobilization on human muscle fibres.
Eur J Appl Physiol, 43 (1980), pp. 25-34
[20.]
S.V. Brooks, J.A. Faulkner.
Effect of aging on structure and function of skeletal muscle.
The thorax: part A, pp. 295-312
[21.]
K. Tolep, S. Kelsen.
Effect of aging on respiratory skeletal muscles.
Clin Chest Med, 14 (1993), pp. 363-378
[23.]
Y.L. Zhang, S.G. Kelsen.
Effects of aging on diaphragm contractile function in golden hamsters.
Am Rev Respir Dis, 142 (1990), pp. 1396-1401
[24.]
E. Zerba, T.E. Komorowski, J.A. Faulkner.
The role of free radicals in skeletal muscle in young, adult and old mice.
Am J Physiol, 258 (1990), pp. C429-C435
[25.]
S.V. Brooks, J.A. Faulkner.
Contraction-induced injury: Recovery of skeletal muscles of young and old mice.
Am J Physiol, 258 (1990), pp. C436-C442
[26.]
G. Desypris, D.J. Parri.
Relative efficacy of slow and fast motoneurons to reinnervate mouse soleus muscle.
Am J Physiol, 4258 (1990), pp. C62-C70
[27.]
G. Stassijns, R. Lysens, M. Decramer.
Peripheral and respiratory muscles in chronic heart failure.
Eur Respir J, 9 (1996), pp. 2161-2167
[28.]
H.R. Gosker, E.F.M. Wounters, G.J. Van der Vusse, A.M. Schols.
Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perpectives.
Am J Clin Nutr, 71 (2000), pp. 1033-1047
[29.]
N.P. Buller, D. Jones, P.A. Poole-Wilson.
Direct measurement of skeletal muscle fatigue in patients with chronic heart failure.
Br Heart J, 65 (1991), pp. 20-24
[30.]
J.R. Minotti, I. Chritoph, R. Oka, M.W. Weiner, L. Wells, B.M. Massie.
Impaired skeletal muscle function in patients with congestive heart failure: relationship to systemic exercise performance.
J Clin Invest, 88 (1991), pp. 2077-2082
[31.]
M. Schaufelberger, B.O. Ericksson, G. Grimby, P. Held, K. Swedberg.
Skeletal muscle alterations in patients with chronic heart failure.
Eur Heart J, 18 (1997), pp. 971-980
[32.]
H. Drexler, U. Riede, T. Munzel, H. Koning, E. Funke, H. Just.
Alterations of skeletal muscle in chronic heart failure.
Circulation, 85 (1992), pp. 1751-1759
[33.]
J.R. Minotti, P. Pillary, L. Chang, L. Wells, B.M. Massie.
Neurophysiological assessment of skeletal muscle fatigue in patients with congestive heart failure.
Circulation, 86 (1992), pp. 903-908
[34.]
R. Casaburi.
Skeletal muscle function in COPD.
Chest, 117 (2000), pp. 2675-2715
[35.]
A.M. Schols, W.A. Buurman, A.J. Stael Van den Brekel, M.A. Dentener, E.F.M. Wonters.
Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease.
Thorax, 51 (1996), pp. 819-824
Copyright © 2001. Sociedad Española de Neumología y Cirugía Torácica
